Summit Therapeutics shared on LinkedIn:
“We are looking forward to attending the IASLC 2026 World Conference on Lung Cancer (WCLC) and are excited to be part of this important event!
To learn more about Summit’s phase 3 clinical studies.
For more information on the congresses that Team Summit is attending, visit here.”
Other articles about WCLC26 on OncoDaily.